Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Esophageal Neoplasms 44Esophageal Squamous Cell Carcinoma 18Carcinoma, Squamous Cell 6Neoplasms 4Adenocarcinoma 4Sarcopenia 2Radiation Injuries 2Obesity 2Anastomotic Leak 2Stomach Neoplasms 1Respiratory Insufficiency 1Radiation Pneumonitis 1Radiation Fibrosis Syndrome 1Pulmonary Fibrosis 1Postoperative Complications 1Pneumonia 1Pathologic Complete Response 1Pain, Postoperative 1Osteoporosis 1Obesity, Abdominal 1Neoplastic Cells, Circulating 1National Cancer Center/Cancer Hospital 1Motor Activity 1Margins of Excision 1Lymphatic Metastasis 1Loco-regional Esophageal Cancer 1Esophageal Diseases 1Deglutition Disorders 1Clinical Stage I Esophageal Adenocarcinoma AJCC v8 1Brain Neoplasms 1

Interventions

Carboplatin 7Trastuzumab 6Docetaxel 5pembrolizumab 4Paclitaxel 4Oxaliplatin 4Fluorouracil 4Cytarabine 4Cyclophosphamide 4Azacitidine 4pertuzumab 3Radiotherapy 3Observation 3Neoadjuvant Therapy 3Epirubicin 3Endoscopy 3Cisplatin 3Chemoradiotherapy 3Capecitabine 3venetoclax 2toripalimab 2sargramostim 2olaparib 2durvalumab 2cc-486 2Tretinoin 2Surgical Procedures, Operative 2Standard of Care 2Pemetrexed 2Monatide (IMS 3015) 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pathologic Complete Response × Esophagectomy × Clear all
NCT04006041 2019-12-26

Combination of Toripalimab and Neoadjuvant Chemoradiotherapy in Esophageal Cancer

Sun Yat-sen University

Phase 2 Unknown
44 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma, Pathologic Complete Response

Data powered by HemOnc (CC BY 4.0) Colophon âš¡